Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors
|
Children's Hospital Los Angeles / William May |
Innovation Grants |
2008 |
California |
Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2018 |
California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress |
Children's Hospital Los Angeles / Jessica Ward, PhD |
Nurse Researcher Fellowship Grant |
2017 |
California |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors |
University of California, Davis / Wolf-Dietrich Heyer, PhD |
Innovation Grants |
2018 |
California |
Pain and Symptom Experiences in Children with Cancer |
University of California, Los Angeles / Eufemia Jacob, PhD, RN |
Nurse Researcher Grants |
2007 |
California |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
Stanford University School of Medicine / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |